These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
156 related items for PubMed ID: 16118377
1. Risk of death with nesiritide. Burger AJ. JAMA; 2005 Aug 24; 294(8):897; author reply 898. PubMed ID: 16118377 [No Abstract] [Full Text] [Related]
2. Pharmacoeconomic modeling of nesiritide versus dobutamine for decompensated heart failure. Gerhard T, Zineh I, Winterstein AG, Hartzema AG. Pharmacotherapy; 2006 Jan 24; 26(1):34-43. PubMed ID: 16509026 [Abstract] [Full Text] [Related]
3. Concomitant use of nesiritide and milrinone in decompensated congestive heart failure. Smull DL, Jorde UP. Am J Health Syst Pharm; 2005 Feb 01; 62(3):291-5. PubMed ID: 15719588 [No Abstract] [Full Text] [Related]
4. Risk of death associated with nesiritide in patients with acutely decompensated heart failure. Aaronson KD, Sackner-Bernstein J. JAMA; 2006 Sep 27; 296(12):1465-6. PubMed ID: 17003394 [No Abstract] [Full Text] [Related]
5. Risk of death with nesiritide. Gortney JS, Porter KB. JAMA; 2005 Aug 24; 294(8):897-8; author reply 898. PubMed ID: 16118376 [No Abstract] [Full Text] [Related]
9. Nesiritide is beneficial or harmful to patients with decompensated acute congestive heart failure. Ma X, Sun F, Ma J. Int J Cardiol; 2015 Jul 14; 187():387-8. PubMed ID: 25841132 [No Abstract] [Full Text] [Related]
10. Nesiritide vs nitroglycerin for decompensated congestive heart failure. Rifkin W. JAMA; 2002 Aug 07; 288(5):572; author reply 572-3. PubMed ID: 12150662 [No Abstract] [Full Text] [Related]
11. Re: Critical review and recommendations for nesiritide use in the Emergency Department. Levine M. J Emerg Med; 2007 Feb 07; 32(2):207-8; author reply 208-9. PubMed ID: 17307636 [No Abstract] [Full Text] [Related]
12. Nesiritide--not verified. Schreiner G. N Engl J Med; 2005 Oct 06; 353(14):1525-7; author reply 1525-7. PubMed ID: 16211709 [No Abstract] [Full Text] [Related]
14. The lost decade of nesiritide. Topol EJ. N Engl J Med; 2011 Jul 07; 365(1):81-2. PubMed ID: 21732841 [No Abstract] [Full Text] [Related]
15. Controversy and conflict in the treatment of acute decompensated heart failure: limited role for nesiritide. Noviasky JA. Pharmacotherapy; 2007 May 07; 27(5):626-32. PubMed ID: 17461696 [Abstract] [Full Text] [Related]
16. Efficacy and safety of nesiritide in patients with acute decompensated heart failure. DeWald TA, Hernandez AF. Expert Rev Cardiovasc Ther; 2010 Feb 07; 8(2):159-69. PubMed ID: 20136602 [Abstract] [Full Text] [Related]
17. Dobutamine Therapy is Associated with Worse Clinical Outcomes Compared with Nesiritide Therapy for Acute Decompensated Heart Failure: A Systematic Review and Meta-Analysis. Wang XC, Zhu DM, Shan YX. Am J Cardiovasc Drugs; 2015 Dec 07; 15(6):429-37. PubMed ID: 26123415 [Abstract] [Full Text] [Related]
20. Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials. Sackner-Bernstein JD, Kowalski M, Fox M, Aaronson K. JAMA; 2005 Apr 20; 293(15):1900-5. PubMed ID: 15840865 [Abstract] [Full Text] [Related] Page: [Next] [New Search]